Related Experiment Video
Updated: Feb 16, 2026

A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Diffuse alveolar haemorrhage complicated by pulmonary embolism - problems with treatment
Justyna Fijołek1, Elzbieta Wiatr, Lilia Jakubowska
1The Third Department of Pneumonology,, Warsaw, Poland. jfijolek@op.pl.
Diffuse alveolar hemorrhage (DAH) is a serious lung condition. This case highlights the dangerous link between DAH and blood clots like pulmonary embolism in anti-GBM disease.
Area of Science:
- Pulmonology
- Nephrology
- Hematology
Background:
- Diffuse alveolar hemorrhage (DAH) is a critical syndrome caused by alveolar capillary damage, leading to red blood cell accumulation in lung air spaces.
- The prognosis and treatment of DAH depend heavily on associated conditions and the underlying disease.
- Co-occurrence of DAH with venous thromboembolism (VTE) presents significant clinical and therapeutic challenges.
Observation:
- A young patient presented with massive DAH.
- The DAH occurred during the course of anti-glomerular basement membrane (anti-GBM) disease, also known as Goodpasture's syndrome.
- The patient's condition was complicated by a pulmonary embolism (PE).
Findings:
- This case illustrates a rare but severe presentation of anti-GBM disease.
- The simultaneous occurrence of DAH and PE in this context underscores the complexity of managing such patients.
- Effective therapeutic strategies require careful consideration of both the autoimmune disease and thromboembolic risks.
Implications:
- This case emphasizes the need for heightened awareness of VTE in patients with anti-GBM disease and DAH.
- It highlights the diagnostic and therapeutic challenges in managing patients with concurrent DAH and PE.
- Further research may elucidate optimal anticoagulation and immunosuppressive strategies for this specific patient population.
More Related Videos
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Diffusion
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

